Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98.7M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
42.3M
-
Shares change
-
+4.35M
-
Total reported value, excl. options
-
$1.71B
-
Value change
-
+$34M
-
Put/Call ratio
-
2.34
-
Number of buys
-
134
-
Number of sells
-
-78
-
Price
-
$40.34
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q4 2020
261 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q4 2020.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.3M shares
of 98.7M outstanding shares and own 42.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.45M shares), Silver Lake Group, L.L.C. (3.03M shares), MORGAN STANLEY (2.7M shares), GOLDMAN SACHS GROUP INC (2.31M shares), FMR LLC (2.22M shares), TIGER GLOBAL MANAGEMENT LLC (2.15M shares), Invesco Ltd. (2.13M shares), LIGHT STREET CAPITAL MANAGEMENT, LLC (2.03M shares), ZEVENBERGEN CAPITAL INVESTMENTS LLC (1.66M shares), and BlackRock Inc. (1.57M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.